Skip to main content

Funding

  • Grant: #U01DA050330
    • Principal Investigator: Norman, Andrew
    • Dates: 09-15-2019 -07-31-2022
    • Funding Agency: National Institute on Drug Abuse
    • Title: IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody Role
    • Total Project Funding: $1,796,316.00
    • Status: Avtive
  • Grant: #U01DA048525
    • Principal Investigator: Norman, Andrew
    • Dates: 07-01-2019 -04-30-2022
    • Funding Agency: National Institute on Drug Abuse
    • Title: First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody Role
    • Total Project Funding: $4,770,702.00
    • Status: Active
  • Grant: #U01DA039550
    • Principal Investigator: Norman, Andrew
    • Dates: 08-01-2015 - 05-31-2018
    • Funding Agency: National Institutes of Health
    • Title: Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody
    • Total Project Funding: $6,259,187.00
    • Status: Active
  • Grant: #DP1 DA031386
    • Principal Investigator: Norman, Andrew
    • Dates: 09-30-2010 - 07-31-2015
    • Funding Agency: National Institute on Drug Abuse
    • Title: A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
    • Total Project Funding: $3,800,342.00
    • Status: Completed
  • Grant: #P2D R43 DA023294
    • Subcontract Principal Investigator: Norman, Andrew
    • Dates: 04-01-2007 - 03-31-2008
    • Funding Agency: National Institute on Drug Abuse
    • Title: Cocaine Therapeutic: PD2007DA Transport Inhibitor
    • Total Project Funding $57,085.00
    • Status: Competed
  • Grant: #44DA018538
    • Principal Investigator: Norman, Andrew
    • Dates: 09-01-2004 - 12-31-2009
    • Funding Agency: National Institute On Drug Abuse
    • Title: A human antibody as an immunotherapy for cocaine abuse
    • Total Project Funding: $2,975,367.00
    • Status: Completed
  • Grant: #5-U19-DA-12043-05-A0-S0-E0
    • Principal Investigator: Norman, Andrew
    • Dates: 09-01-1998 - 12-31-2004
    • Funding Agency: National Institute on Drug Abuse
    • Title: Passive Immunity to Cocaine Using Novel Human Antibodies
    • Total Project Funding: $4,862,093.00
    • Status: Completed
Intranet Login
Directory Search

Contact Us

Department of
Pharmacology, Physiology, & Neurobiology
College of Medicine
231 Albert Sabin Way
Cincinnati, OH 45267-0575